Skip to main navigation Skip to search Skip to main content

Development of ultrasonic cancer therapy using ultrasound sensitive liposome

  • Teikyo University

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Ultrasound (US) has been utilized as a useful tool for diagnosis and therapy. US mediated drug and gene delivery is paid to attention as a non-invasive system. The combination of US and microbubbles generated microjet stream by inducing disruption of bubbles and resulted in enhancing permeability of cell membrane. This phenomenon has been utilized as driving force for drug and gene delivery. Recently, we developed ultrasound sensitive liposome [Bubble liposome (BL)] containing perfluoropropane gas. US combined with BL could effectively transfer gene in vivo compared to conventional cationic liposomes. Using this method, we succeeded to obtain a therapeutic effect in cancer gene therapy with Interleukin-12 corded plasmid DNA. Therefore, it is expected that US combined with BL might be a useful nonviral vector system. From this result, the fusion of liposomal and ultrasound technologies would be important for establishment of advanced cancer therapy.

Original languageEnglish
Pages (from-to)1665-1670
Number of pages6
JournalYakugaku Zasshi
Volume130
Issue number12
DOIs
StatePublished - Dec 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Drug delivery system (DDS)
  • Gene therapy
  • Liposome
  • Non-viral vector
  • Ultrasound

Fingerprint

Dive into the research topics of 'Development of ultrasonic cancer therapy using ultrasound sensitive liposome'. Together they form a unique fingerprint.

Cite this